Should surgery be carried out in patients with hepatocellular carcinoma with portal hypertension?

Tian Yang¹, Wan Yee Lau^{1

2}, Han Zhang¹, Mengchao Wu¹, Feng Shen¹

Affiliations

¹ Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
² Faculty of Medicine, The Chinese University of Hong Kong, HKSAR, China.

Comment

Tian Yang et al. Hepatology. 2015 Sep.

. 2015 Sep;62(3):976.

doi: 10.1002/hep.27703. Epub 2015 Feb 27.

Tian Yang¹, Wan Yee Lau^{1

2}, Han Zhang¹, Mengchao Wu¹, Feng Shen¹

¹ Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
² Faculty of Medicine, The Chinese University of Hong Kong, HKSAR, China.

No abstract available

Comment in

Reply: To PMID 25212123.
Berzigotti A, Reig M, Bruix J. Berzigotti A, et al. Hepatology. 2015 Sep;62(3):978-9. doi: 10.1002/hep.27701. Epub 2015 Mar 10. Hepatology. 2015. PMID: 25598299 No abstract available.

Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis.
Berzigotti A, Reig M, Abraldes JG, Bosch J, Bruix J. Berzigotti A, et al. Hepatology. 2015 Feb;61(2):526-36. doi: 10.1002/hep.27431. Epub 2015 Jan 5. Hepatology. 2015. PMID: 25212123